TAO Synergies TAOX
NASDAQ TAOX
$4.07 +0.06 (+1.49%)
As of: Sep 9, 2026 · 11:14 AM EDT

TAO Synergies (TAOX) EBITDA (2019 - 2026)

TAO Synergies' (TAOX) quarterly EBITDA came in at -$1.6 million in Q2 2026, up 48.31% on a YoY basis from -$1.1 million in Q2 2025, and down 19.08% quarter-over-quarter from -$1.3 million in Q1 2026.

Analysis

TAO Synergies (TAOX) EBITDA (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported EBITDA for 8 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EBITDA rose 48.31% year-over-year to -$1.6 million; the trailing twelve-month figure through Jun 2026 stood at -$7.8 million (down 2.43% YoY), and the FY2025 full-year result was -$9.0 million, down 32.84% from the prior year.
  • EBITDA retreated to -$1.6 million in Q2 2026 per TAOX's latest filing, from -$1.3 million in the prior quarter.
  • Across five years, EBITDA topped out at $4.5 million in Q4 2022 and bottomed at -$4.1 million in Q2 2023.
  • Historically, EBITDA has averaged -$1.6 million across 5 years, with a median of -$1.6 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: EBITDA surged 205.81% in 2022, then slumped 417.26% in 2025.
  • Over 5 years, EBITDA stood at $4.5 million in 2022, then tumbled by 122.22% to -$995969.0 in 2023, then tumbled by 56.65% to -$1.6 million in 2024, then sank by 101.42% to -$3.1 million in 2025, then surged by 50.07% to -$1.6 million in 2026.
  • According to Business Quant data, EBITDA over the past three periods registered -$1.6 million, -$1.3 million, and -$3.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Amgen 212.35 Bn 198.36 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 181.19 Bn 178.01 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 132.48 Bn 124.62 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.59 Bn 74.60 Bn 3.93 Bn 1.29 Bn
5 Argenx Se 61.45 Bn 56.27 Bn 1.37 Bn 493.00 Mn
6 Moderna 54.89 Bn 49.75 Bn 52.00 Mn -815.00 Mn
7 Alnylam Pharmaceuticals 34.21 Bn 30.90 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.38 Bn 30.10 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 29.81 Bn 29.81 Bn 1.16 Mn -365.99 Mn
10 TAO Synergies 30.41 Mn 30.41 Mn - -1.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.57 Mn
Mar 31, 2026 -1.32 Mn
Dec 31, 2025 -3.14 Mn
Sep 30, 2025 -1.80 Mn
Jun 30, 2025 -3.04 Mn
Mar 31, 2025 -1.07 Mn
Dec 31, 2024 -1.56 Mn
Sep 30, 2024 -1.98 Mn
Jun 30, 2024 -1.58 Mn
Mar 31, 2024 -206,699.00
Dec 31, 2023 -995,969.00
Sep 30, 2023 763,203.00
Jun 30, 2023 -4.09 Mn
Mar 31, 2023 -1.71 Mn
Dec 31, 2022 4.48 Mn
Sep 30, 2022 -3.03 Mn
Jun 30, 2022 -3.75 Mn
Mar 31, 2022 -3.28 Mn
Dec 31, 2021 -4.24 Mn
Sep 30, 2021 -2.93 Mn